Xp Inc.

You are paying 9.3x earnings for a broker sitting on R$1.2 trillion in client assets.

If you own XP, your money is tied to a Brazilian platform that moves client cash and investments.

xp

financials mid cap updated jan 2, 2026
$16.21
market cap ~$9B · 52-week range $11–$21
xvary composite: 64 / 100 · average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
XP sells financial products to Brazilian savers and companies through a digital investing platform.
how it gets paid
Last year Xp made $3.5B in revenue.
what just happened
XP posted R$4.95B in net revenue and beat EPS by 2.08%.
At a glance
B+ balance sheet — decent shape, but not bulletproof
90/100 earnings predictability — you can trust these numbers
9.3x trailing p/e — the market's not buying it — or you found a deal
2.5% dividend yield — cash in your pocket every quarter
18.5% return on capital — nothing to write home about
xvary composite: 64/100 — average
What they do
XP sells financial products to Brazilian savers and companies through a digital investing platform.
XP sits on R$1.2 trillion in client assets. That is your money, parked in one system. Leaving means moving accounts, investments, and advice history. The company had 7,440 employees at 12/31/24, so this is a large machine, not a corner office.
financials mid-cap wealth-platform client-assets brazil
How they make money
$3.5B annual revenue
total revenue
$3.5B
n/a
The products that matter
investment and banking platform
Retail Platform
R$3.9B · 4.8M clients
it generated R$3.9B in fourth-quarter revenue from 4.8 million clients. that's the core distribution engine.
client funnel
corporate advisory and hedging
Corporate & Issuer Services
R$406M · +77%
revenue reached R$406M in one quarter, up 77% from a year ago. that's a real growth pocket, even if it's not the whole company.
fastest growth
consumer and corporate lending
Credit Portfolio
R$67B · +33%
the loan book grew 33% to R$67B. that's good when credit stays clean and less fun when the economy slows.
risk pivot
Key numbers
R$1.2T
client assets
That is the money XP can charge against. More assets usually mean more fee collection without more branches.
9.3x
trailing p/e
You pay 9.3 years of past earnings for the stock. That is cheap next to a 36.5% operating margin.
36.5%
op margin
XP keeps 36.5 cents of every revenue dollar before interest and tax. That gives the business a real cushion.
2.5%
dividend yield
You get $2.50 a year for every $100 invested. That is cash while you wait for the stock to catch up.
Financial health
B+
strength
  • balance sheet grade B+ — solid but not elite
  • risk rank 3 — safer than 50% of stocks
  • price stability 20 / 100
  • net profit margin 27.8% — keeps 28 cents of every dollar in revenue
  • return on equity 23% — $0.23 profit for every $1 investors have put in
B+ — functional but not a standout on the balance sheet.
Total return vs. market

You invested $10,000 in XP 3 years ago → it's now worth $12,140.

The index would have given you $13,920.

source: institutional data · total return
What just happened
beat estimates
XP posted R$4.95B in net revenue and beat EPS by 2.08%.
Net revenue rose to R$4.95B from R$4.49B, while gross profit rose to R$3.42B from R$3.11B. The company also printed $0.49 per share against a $0.48 estimate.
R$4.95B
revenue
$0.49
eps
69.0%
gross margin
net revenue
R$4.95B mattered because it was 10% above R$4.49B, which says the platform still pulls in cash.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the #1 risk is brazilian credit stress hitting a R$67B loan book.

!
high
brazilian credit stress
the loan portfolio grew 33% to R$67B. if brazil weakens, delinquencies and provisioning become the story fast.
this risk now touches a balance-sheet exposure large enough to matter to the whole thesis, not just a side business.
med
market-sensitive fee income
xp gathered R$1.5T in client assets, but asset-based fees and trading activity still depend on healthy client engagement. fixed-income revenue already fell 7%.
if investors get cautious, cleaner fee revenue can slow even before credit losses show up.
med
margin slippage below guidance
management is guiding to a 30–34% EBT margin in 2026. if costs rise or revenue mix shifts the wrong way, the stock loses one of its cleanest support beams.
miss the margin range and the 9.3x multiple can stay cheap for a reason.
~
low
regulatory pressure on distribution and fees
with 4.8M clients and a large open platform, xp sits close to brazilian retail-investor regulation. tighter rules can slow product rollout or compress take rates.
the damage would likely show up first in margins, not revenue headline growth.
a weaker brazil would pressure both sides of the model at once: the R$67B loan portfolio and the R$1.5T asset base that feeds fee income.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
2026 ebt margin at 30–34%
this is the cleanest management promise on the page. hit it, and the platform story holds. miss it, and the low multiple starts making sense.
calendar
Q1 2026 earnings
late april 2026. you want to see whether R$29B net new money was a one-quarter spike or the start of a better inflow trend.
trend
credit growth versus fee growth
the loan book grew 33%. fixed-income revenue fell 7%. if credit keeps outrunning fee businesses, your valuation framework has to shift with it.
risk
retail inflows near the R$20B pace
management has pointed to about R$20B in quarterly retail inflows. if that fades while lending stays hot, the business mix gets less comfortable.
Analyst rankings
earnings predictability
90 / 100
management usually lands close to expectations. in human-speak, analysts trust the model more than they trust the stock.
timeliness
2
top 20% for short-term outlook. analysts think XP can outperform most stocks over the next 12 months.
source: institutional data
Institutional activity

institutions have been net buying for 3 consecutive quarters — 173 buyers vs. 155 sellers in 3q2025. total institutional holdings: 0.3B shares. net buying for 3 quarters.

source: institutional data
Price targets
3-5 year target range
$6 $21
$16 current price
$14 target midpoint · 14% from current · 3-5yr high: $45 (+180% · 31% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
XP
xvary deep dive
xp
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it